Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05910437
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-14
First Post:
2023-04-28
Brief Title:
Optimizing Treatments for Heart Failure During Hospitalization
Sponsor:
Central Hospital Nancy France
Organization:
Central Hospital Nancy France
Study Overview
Official Title:
Optimizing Treatments for Heart Failure During Hospitalization
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OPTICARD
Brief Summary:
Heart failure reaches 15 million people in France and is responsible for 200000 hospitalizations per year
Over the past ten years new therapies have emerged treatment of martial deficiency Entresto iSGLT2
Hospitalization in a context of acute heart failure is a moment of choice in the history of the disease to introduce recommended treatments under closer supervision clinical biological than in ambulatory and allows a decrease in hospitalizations morbidity and mortality
The purpose of this study is to describe the introduction of heart failure drugs including iSGLT2 in real-life settings in patients hospitalized for decompensated heart failure
Over the past ten years new therapies have emerged treatment of martial deficiency Entresto iSGLT2
Hospitalization in a context of acute heart failure is a moment of choice in the history of the disease to introduce recommended treatments under closer supervision clinical biological than in ambulatory and allows a decrease in hospitalizations morbidity and mortality
The purpose of this study is to describe the introduction of heart failure drugs including iSGLT2 in real-life settings in patients hospitalized for decompensated heart failure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None